| ²é¿´: 1307 | »Ø¸´: 6 | ||
ÑîСæÃÌú³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
¹úÍâÉÏÊд¦·½²éѯ ÒÑÓÐ3È˲ÎÓë
|
| °¢Ë¹Àû¿µµÄAXANUMÔÚÅ·ÖÞÅú×¼ÉÏÊУ¬ÄÜ·ñ°ïæ²éµ½´¦·½Ñ½£¿ÐÂÊÖÉÏ·£¬Çë¶à¶àÖ¸½Ì¡£ |
» ²ÂÄãϲ»¶
ÇóÀÏʦÊÕÁô
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤085600£¬Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
ר˶085601Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé
ÒѾÓÐ7È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
260Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
326Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
µ÷¼Á
ÒѾÓÐ4È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏÓ뻯¹¤306·ÖÕÒµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÔÚÄÄÀï¿ÉÒÔ²éѯҩƷרÀûÓÐЧÆÚѽ£¿¹úÍâµÄÒ©Æ·
ÒѾÓÐ7È˻ظ´
ÈçºÎ»ñÈ¡¹úÄÚÍâÒÑÉÏÊÐÒ©Æ·µÄÏà¹Ø²ÄÁÏ
ÒѾÓÐ10È˻ظ´
ÑÎËáëÒ·¨ÐÁµÄ¹úÍâÉÏÊÐÇé¿ö
ÒѾÓÐ7È˻ظ´
Ò©Æ·ÔÑг§¼ÒµÄ²éѯ
ÒѾÓÐ15È˻ظ´
Ò»¸öÒѾÓÐÁËÅú×¼ºÅµÄÒ©Æ·£¬ÈçºÎ²éËüµ±Ê±É걨ʱµÄ×¢²á·ÖÀà
ÒѾÓÐ18È˻ظ´
ÈçºÎ²éѯ¹úÍâÉÏÊÐʱ¼ä±È½Ï¶ÌµÄÒ©ÎïµÄÖÊÁ¿±ê×¼
ÒѾÓÐ4È˻ظ´
ÇëÎÊ£ºÏÖÔÚ¹úÍâÉÏÊа¢¿¨²¨ÌǺͶþ¼×Ë«ëҵĸ´·½Æ¬ÁËÂð
ÒѾÓÐ4È˻ظ´
¶ÔÓÚ²éѯҩƷÔÑг§¼ÒµÄ·½·¨
ÒѾÓÐ3È˻ظ´
¹úÍâ´¦·½Ò©µÄ»ñȡ;¾¶
ÒѾÓÐ18È˻ظ´
ÈçºÎ²éÕÒijҩÎïÔÚ¹úÍâµÄÉÏÊÐÐÅÏ¢
ÒѾÓÐ4È˻ظ´
¹úÍâÉÏÊÐÓÎÀë¼î£¬¹úÄÚûÓÐÉÏÊУ¬ÎÒ¹«Ë¾×ö³ÉÁòËáÑΣ¬°´ÕÕ¼¸À౨Åú£¨»¯Ò©£©
ÒѾÓÐ16È˻ظ´
²éÕÒ¹úÍâÉÏÊÐchondrosulf£¨Å·ÖÞ£©£¬menopure£¨º«¹ú£©µÄ˵Ã÷ÊéºÍ´¦·½£¡
ÒѾÓÐ4È˻ظ´
¼±Çó¹úÍâÉÏÊУ¬¹úÄÚδÉÏÊÐҩƷ˵Ã÷ÊéµÄ¼ìË÷·½·¨£¡
ÒѾÓÐ12È˻ظ´
ͨ¹ýʲô;¾¶¿ÉÒԲ鵽ijÖÖÒ©Æ·ÖÐËùº¬µÄ¸¨ÁÏ£¿
ÒѾÓÐ10È˻ظ´
¡¾×ªÌû¡¿Ò©Æ·²éÑ¯ÍøµÄÊý¾Ý¿â
ÒѾÓÐ77È˻ظ´
¡¾½»Á÷¡¿ÈܳöÌõ¼þµÄÑ¡ÔñÎÊÌâ
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿ÈçºÎѰÕÒ¶àëÄÉÏÊÐÒ©ÎÓÐÄÄÐ©ÍøÕ¾£¿
ÒѾÓÐ11È˻ظ´
canmeng525
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1738.1
- ºì»¨: 7
- Ìû×Ó: 321
- ÔÚÏß: 204Сʱ
- ³æºÅ: 836407
- ×¢²á: 2009-08-29
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
Esomeprazole component glycerol monostearate 40-55 hydroxypropylcellulose hypromellose magnesium stearate methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30 per cent (may contain sodium dodecyl sulphate and polysorbate 80) polysorbate 80 sodium stearyl fumarate sugar spheres (contain sucrose and maize starch) talc triethyl citrate Acetylsalicylic acid component low-substituted hydroxypropylcellulose Hard gelatine capsule, reddish pink/grey size 3 gelatine iron oxide red (E172) iron oxide black (E172) titanium dioxide (E171) Ink black, SW-9008 iron oxide black (E172) potassium hydroxide shellac propylene glycol |

2Â¥2014-02-10 16:48:26
fishlone
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 50 (СѧÉú)
- ½ð±Ò: 9.7
- É¢½ð: 575
- ºì»¨: 5
- Ìû×Ó: 1427
- ÔÚÏß: 154.9Сʱ
- ³æºÅ: 1632307
- ×¢²á: 2012-02-21
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
EMEAÍøÕ¾ÀïÃæÓа¡£¬ÏÂÔØ¼¸¸öÅú×¼Îļþ¿´Ï¡£ Esomeprazole component glycerol monostearate 40-55 hydroxypropylcellulose hypromellose magnesium stearate methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30 per cent (may contain sodium dodecyl sulphate and polysorbate 80) polysorbate 80 sodium stearyl fumarate sugar spheres (contain sucrose and maize starch) talc triethyl citrate Acetylsalicylic acid component low-substituted hydroxypropylcellulose Hard gelatine capsule, reddish pink/grey size 3 gelatine iron oxide red (E172) iron oxide black (E172) titanium dioxide (E171) Ink black, SW-9008 iron oxide black (E172) potassium hydroxide shellac propylene glycol |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
3Â¥2014-02-11 16:38:26
ÑîСæÃ
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 175
- Ìû×Ó: 4
- ÔÚÏß: 27.1Сʱ
- ³æºÅ: 1777451
- ×¢²á: 2012-04-25
- רҵ: Ò©¼Áѧ
4Â¥2014-02-12 15:02:45
ÑîСæÃ
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 175
- Ìû×Ó: 4
- ÔÚÏß: 27.1Сʱ
- ³æºÅ: 1777451
- ×¢²á: 2012-04-25
- רҵ: Ò©¼Áѧ
5Â¥2014-02-12 15:56:06
ÑîСæÃ
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 175
- Ìû×Ó: 4
- ÔÚÏß: 27.1Сʱ
- ³æºÅ: 1777451
- ×¢²á: 2012-04-25
- רҵ: Ò©¼Áѧ
6Â¥2014-02-13 09:00:45
ÕÔÏ£Çà
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1684.2
- É¢½ð: 180
- ºì»¨: 2
- Ìû×Ó: 109
- ÔÚÏß: 34.2Сʱ
- ³æºÅ: 2072155
- ×¢²á: 2012-10-19
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
7Â¥2014-02-15 09:27:58














»Ø¸´´ËÂ¥
ÑîСæÃ